| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,875 | 8,662 | 8,494 | 7,397 | | Cost of Revenue | 5,368 | 5,320 | 5,776 | 5,076 | | | Gross Profit | 3,507 | 3,342 | 2,717 | 2,321 | | | Operating Expenses | | Research Development | 662 | 686 | 996 | 3,647 | | Selling General and Administrative | 3,892 | 4,906 | 4,236 | 1,222 | | Non Recurring | 873 |
-
| 37,614 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,919) | (2,250) | (40,128) | (2,548) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (17) | (1) | 531 | | Earnings Before Interest And Taxes | (2,342) | (2,267) | (40,129) | (2,017) | | Interest Expense | (299) | 140 | 159 | 144 | | Income Before Tax | (2,043) | (2,407) | (40,288) | (2,161) | | Income Tax Expense |
-
|
-
| 600 |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,043) | (2,407) | (40,888) | (2,161) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,043) | (2,407) | (40,888) | (2,161) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,043) | ($2,407) | ($40,888) | ($2,161) |
|
0.51% Nasdaq 
Income Statement
